Anterix (NASDAQ:ATEX) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.52) by 32.69 percent. The company reported quarterly sales of $1.551 million which missed the analyst consensus estimate of $1.747 million by 11.24 percent. This is a 47.43 percent increase over sales of $1.052 million the same period last year.